
Sign up to save your podcasts
Or


đOur WYNDEX (Whatâs Your Number Index) update for today:
Markets were up this week, but the WYNDEX slipped again. Yonatan and Yael break down the biggest movers, including Nova leading the pack and monday.com falling to the bottom, plus what the Fed shakeup and a sudden drop in gold and silver signaled to investors.
đ Our Long Play Yonatan and Yael are joined by Daphne Koller, CEO and founder of insitro and co-founder of Coursera, for a wide-ranging conversation on insitroâs acquisition of CombinAble.AI. They explore why drug discovery still has a 90% failure rate, how AI can help uncover entirely new biological targets, what it takes to turn targets into real medicines, and why Israelâs talent ecosystem matters at the intersection of AI and biology.
This episode was sponsored by SAPIR: Sign up for the SAPIR journal at sapirjournal.org/whatsyournumber
01:00 - Numbers of the Week
05:00 - The Wyndex
10:40 - Big Short #1: Apple acquires Israeli startup Q.ai
14:40 - Big Short #2: United Nations financial crunch and global credibility
19:20 - Long Play: Daphne Koller on AI drug discovery
42:40 - Words of the Week
Find us on:
YouTube
Yael on XÂ
Yonatan on X
Write to us here
New episodes drop on Wednesdays
LEGAL DISCLAIMER
This podcast offers general business and economic information and is not a comprehensive summary for investment decisions. It does not recommend or solicit any investment strategy or security.Â
CREDITS:
Hosts - YONATAN ADIRI & YAEL WISSNER-LEVY
Executive Producer - ADAAM JAMES LEVIN-AREDDY
Production Manager - BRITTANY COHEN
Sound and Video editing - MARTIN HUERGO AND PATRICIO SPADAVECCHIA
Music - MIDNIGHT GENERATION
By Ark Media4.9
121121 ratings
đOur WYNDEX (Whatâs Your Number Index) update for today:
Markets were up this week, but the WYNDEX slipped again. Yonatan and Yael break down the biggest movers, including Nova leading the pack and monday.com falling to the bottom, plus what the Fed shakeup and a sudden drop in gold and silver signaled to investors.
đ Our Long Play Yonatan and Yael are joined by Daphne Koller, CEO and founder of insitro and co-founder of Coursera, for a wide-ranging conversation on insitroâs acquisition of CombinAble.AI. They explore why drug discovery still has a 90% failure rate, how AI can help uncover entirely new biological targets, what it takes to turn targets into real medicines, and why Israelâs talent ecosystem matters at the intersection of AI and biology.
This episode was sponsored by SAPIR: Sign up for the SAPIR journal at sapirjournal.org/whatsyournumber
01:00 - Numbers of the Week
05:00 - The Wyndex
10:40 - Big Short #1: Apple acquires Israeli startup Q.ai
14:40 - Big Short #2: United Nations financial crunch and global credibility
19:20 - Long Play: Daphne Koller on AI drug discovery
42:40 - Words of the Week
Find us on:
YouTube
Yael on XÂ
Yonatan on X
Write to us here
New episodes drop on Wednesdays
LEGAL DISCLAIMER
This podcast offers general business and economic information and is not a comprehensive summary for investment decisions. It does not recommend or solicit any investment strategy or security.Â
CREDITS:
Hosts - YONATAN ADIRI & YAEL WISSNER-LEVY
Executive Producer - ADAAM JAMES LEVIN-AREDDY
Production Manager - BRITTANY COHEN
Sound and Video editing - MARTIN HUERGO AND PATRICIO SPADAVECCHIA
Music - MIDNIGHT GENERATION

30 Listeners

5,177 Listeners

314 Listeners

609 Listeners

200 Listeners

439 Listeners

1,213 Listeners

3,262 Listeners

1,082 Listeners

567 Listeners

8,627 Listeners

446 Listeners

1,095 Listeners

891 Listeners

506 Listeners